PAR2 (1-6) amide (human) (trifluoroacetate salt)
						    			         
			    					
		(Synonyms: SLIGKV-NH2)		目录号 : GC49422
	A peptide agonist of PAR2
     
    
Cas No.:2379569-17-0
Sample solution is provided at 25 µL, 10mM.
PAR2 (1-6) amide is a synthetic peptide agonist of proteinase-activated receptor 2 (PAR2) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR2 and residues 37-42 of the full-length sequence.1 It binds to NCTC 2544 cells expressing human PAR2 (Ki = 9.64 µM in a radioligand binding assay) and induces calcium mobilization in the same cells (EC50 = 0.075 µM).2 PAR2 (1-6) amide (100 µM) reduces colony formation of A549 lung cancer cells.1 It induces superoxide production and degranulation in isolated human eosinophils when used at a concentration of 500 µM.3 PAR2 (1-6) amide (5 µmol/kg) induces tear secretion in rats when used in combination with amastatin .4
1.Bohm, S.K., Kong, W., Bromme, D., et al.Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2Biochem. J.314(Pt 3)1009-1016(1996) 2.Kanke, T., Ishiwata, H., Kabeya, M., et al.Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2Br. J. Pharmacol.145(2)255-263(2005) 3.Miike, S., McWilliam, A.S., and Kita, H.Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2J. Immunol.167(11)6615-6622(2001) 4.Nishikawa, H., Kawai, K., Tanaka, M., et al.Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: Involvement of PAR-2 and non-PAR-2 mechanismsJ. Pharmacol. Exp. Ther.312(2)324-331(2005)
| Cas No. | 2379569-17-0 | SDF | |
| 别名 | SLIGKV-NH2 | ||
| Canonical SMILES | OC[C@H](N)C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@@H](CCCCN)C(N[C@H](C(N)=O)C(C)C)=O)=O)=O)=O)=O.FC(F)(C(O)=O)F | ||
| 分子式 | C28H54N8O7·XCF3COOH | 分子量 | 614.8 | 
| 溶解度 | DMF: 30 mg/ml,DMSO: 15 mg/ml,Ethanol: 5 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | -20°C | 
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 | ||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
|  | 1 mg | 5 mg | 10 mg | 
| 1 mM | 1.6265 mL | 8.1327 mL | 16.2655 mL | 
| 5 mM | 325.3 μL | 1.6265 mL | 3.2531 mL | 
| 10 mM | 162.7 μL | 813.3 μL | 1.6265 mL | 
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
			           2.
			一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
			           3. 以上所有助溶剂都可在 GlpBio 网站选购。
			
Quality Control & SDS
- View current batch:
- Purity: >95.00% 
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
 
 
   
   
   
  














